These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26996993)
1. Construction and expression of an anti-VEGFR2 Nanobody-Fc fusionbody in NS0 host cell. Qasemi M; Behdani M; Shokrgozar MA; Molla-Kazemiha V; Mohseni-Kuchesfahani H; Habibi-Anbouhi M Protein Expr Purif; 2016 Jul; 123():19-25. PubMed ID: 26996993 [TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of a human nanobody against VEGFR-2. Ma L; Gu K; Zhang CH; Chen XT; Jiang Y; Melcher K; Zhang J; Wang M; Xu HE Acta Pharmacol Sin; 2016 Jun; 37(6):857-64. PubMed ID: 27108602 [TBL] [Abstract][Full Text] [Related]
3. Covalently dimerized Camelidae antihuman TNFa single-domain antibodies expressed in yeast Pichia pastoris show superior neutralizing activity. Ji X; Lu W; Zhou H; Han D; Yang L; Wu H; Li J; Liu H; Zhang J; Cao P; Zhang S Appl Microbiol Biotechnol; 2013 Oct; 97(19):8547-58. PubMed ID: 23324801 [TBL] [Abstract][Full Text] [Related]
4. Expression of Human VH Single Domains as Fc Fusions in Mammalian Cells. Abdelatti M; Schofield P; Christ D Methods Mol Biol; 2019; 1953():121-136. PubMed ID: 30912019 [TBL] [Abstract][Full Text] [Related]
5. Introduction to heavy chain antibodies and derived Nanobodies. Vincke C; Muyldermans S Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243 [TBL] [Abstract][Full Text] [Related]
6. Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer. Chabrol E; Fagnen C; Landron S; Marcheteau E; Stojko J; Guenin SP; Antoine M; Fould B; Ferry G; Boutin JA; Vénien-Bryan C Protein Sci; 2021 Sep; 30(9):1946-1957. PubMed ID: 34117809 [TBL] [Abstract][Full Text] [Related]
7. In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody. Richard G; Meyers AJ; McLean MD; Arbabi-Ghahroudi M; MacKenzie R; Hall JC PLoS One; 2013; 8(7):e69495. PubMed ID: 23894495 [TBL] [Abstract][Full Text] [Related]
8. Development of a Recombinant Monospecific Anti-PLGF Bivalent Nanobody and Evaluation of it in Angiogenesis Modulation. Nikooharf A; Arezumand R; Mansouri K; Khoshi AH; Namdar Ahmadabad H Mol Biotechnol; 2020 Dec; 62(11-12):580-588. PubMed ID: 32975735 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody. Kazemi-Lomedasht F; Behdani M; Bagheri KP; Habibi-Anbouhi M; Abolhassani M; Arezumand R; Shahbazzadeh D; Mirzahoseini H Mol Immunol; 2015 May; 65(1):58-67. PubMed ID: 25645505 [TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor. Behdani M; Zeinali S; Khanahmad H; Karimipour M; Asadzadeh N; Azadmanesh K; Khabiri A; Schoonooghe S; Habibi Anbouhi M; Hassanzadeh-Ghassabeh G; Muyldermans S Mol Immunol; 2012 Feb; 50(1-2):35-41. PubMed ID: 22208996 [TBL] [Abstract][Full Text] [Related]
12. Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization. Alirahimi E; Ashkiyan A; Kazemi-Lomedasht F; Azadmanesh K; Hosseininejad-Chafi M; Habibi-Anbouhi M; Moazami R; Behdani M Cancer Gene Ther; 2017 Jan; 24(1):33-37. PubMed ID: 27982020 [TBL] [Abstract][Full Text] [Related]
13. [Construction of anti-VEGFR-2 IgG1 like human antibody and its expression in CHO-k cells]. Li ZK; He Y; Zhang J; Xie W; Cao WL; Wang ZG; Wang M Yao Xue Xue Bao; 2013 Oct; 48(10):1544-9. PubMed ID: 24417080 [TBL] [Abstract][Full Text] [Related]
15. Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis. Burmistrova DA; Tillib SV; Shcheblyakov DV; Dolzhikova IV; Shcherbinin DN; Zubkova OV; Ivanova TI; Tukhvatulin AI; Shmarov MM; Logunov DY; Naroditsky BS; Gintsburg AL PLoS One; 2016; 11(3):e0150958. PubMed ID: 26962869 [TBL] [Abstract][Full Text] [Related]
16. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies]. Xia X; M M; Zhai T; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408 [TBL] [Abstract][Full Text] [Related]
17. Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product. Mohammed A; Zeng W; Mengist HM; Kombe Kombe AJ; Ou H; Yang Y; Dan Z; Xu Z; Ma H; Jin T Biochem Biophys Res Commun; 2021 Dec; 581():38-45. PubMed ID: 34653677 [TBL] [Abstract][Full Text] [Related]
18. Fusion of an Fc chain to a VHH boosts the accumulation levels in Arabidopsis seeds. De Buck S; Nolf J; De Meyer T; Virdi V; De Wilde K; Van Lerberge E; Van Droogenbroeck B; Depicker A Plant Biotechnol J; 2013 Oct; 11(8):1006-16. PubMed ID: 23915060 [TBL] [Abstract][Full Text] [Related]
19. Production of Novel VHH Nanobody Inhibiting Angiogenesis by Targeting Binding Site of VEGF. Ebrahimizadeh W; Mousavi Gargari SL; Javidan Z; Rajabibazl M Appl Biochem Biotechnol; 2015 Aug; 176(7):1985-95. PubMed ID: 26054617 [TBL] [Abstract][Full Text] [Related]
20. Enzymatic functionalization of a nanobody using protein insertion technology. Crasson O; Rhazi N; Jacquin O; Freichels A; Jérôme C; Ruth N; Galleni M; Filée P; Vandevenne M Protein Eng Des Sel; 2015 Oct; 28(10):451-60. PubMed ID: 25852149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]